Other Updated 2022-01-07

Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant

Recalled Product

Casirivimab and Imdevimab


Hazard / Issue

New safety information - COVID

Issued by

Marketed health products

View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon Canada →